1. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*. (1st June 2021) Authors: Blauvelt, A.; Leonardi, C.; Elewski, B.; Crowley, J.J.; Guenther, L.C.; Gooderham, M.; Langley, R.G.; Vender, R.; Pinter, A.; Griffiths, C.E.M.; Tada, Y.; Elmaraghy, H.; Lima, R.G.; Gallo, G.; Renda, L.; Burge, R.; Park, S.Y.; Zhu, B.; Papp, K. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial. (1st June 2021) Authors: Blauvelt, A.; Leonardi, C.; Elewski, B.; Crowley, J.J.; Guenther, L.C.; Gooderham, M.; Langley, R.G.; Vender, R.; Pinter, A.; Griffiths, C.E.M.; Tada, Y.; Elmaraghy, H.; Lima, R.G.; Gallo, G.; Renda, L.; Burge, R.; Park, S.Y.; Zhu, B.; Papp, K. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial. (25th October 2020) Authors: Blauvelt, A.; Leonardi, C.; Elewski, B.; Crowley, J.J.; Guenther, L.C.; Gooderham, M.; Langley, R.G.; Vender, R.; Pinter, A.; Griffiths, C.E.M.; Tada, Y.; Elmaraghy, H.; Lima, R.G.; Gallo, G.; Renda, L.; Burge, R.; Park, S.Y.; Zhu, B.; Papp, K. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial. (4th September 2019) Authors: Elewski, B.E.; Baker, C.S.; Crowley, J.J.; Poulin, Y.; Okun, M.M.; Calimlim, B.; Geng, Z.; Reyes Servin, O.; Rich, P.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 11(2019) Page Start: 2168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. (1st December 2014) Authors: Crowley, J.J.; Mekkes, J.R.; Zouboulis, C.C.; Scheinfeld, N.; Kimball, A.; Sundaram, M.; Gu, Y.; Okun, M.M.; Kerdel, F. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. (20th November 2014) Authors: Crowley, J.J.; Mekkes, J.R.; Zouboulis, C.C.; Scheinfeld, N.; Kimball, A.; Sundaram, M.; Gu, Y.; Okun, M.M.; Kerdel, F. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice. (1st March 2020) Authors: Kimball, A.B.; Crowley, J.J.; Papp, K.; Calimlim, B.; Duan, Y.; Fleischer, A.B.; Sobell, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 6(2020) Page Start: 1302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Defining drug‐free remission of skin disease in patients with plaque psoriasis. (1st June 2020) Authors: Armstrong, A.W.; Blauvelt, A.; Crowley, J.J.; Gordon, K.B.; Krueger, G.G.; Krueger, J.G.; Sobell, J.M.; Strober, B.E.; Srivastava, B.; Menter, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Defining drug‐free remission of skin disease in patients with plaque psoriasis. (29th January 2020) Authors: Armstrong, A.W.; Blauvelt, A.; Crowley, J.J.; Gordon, K.B.; Krueger, G.G.; Krueger, J.G.; Sobell, J.M.; Strober, B.E.; Srivastava, B.; Menter, A. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of adalimumab across subgroups of patients with moderate‐to‐severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH. (22nd June 2013) Authors: Poulin, Y.; Crowley, J.J.; Langley, R.G.; Unnebrink, K.; Goldblum, O.M.; Valdecantos, W.C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 7(2014:Jul.) Page Start: 882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗